Literature DB >> 23835735

A randomized controlled trial of the community-friendly health recovery program (CHRP) among high-risk drug users in treatment.

Michael M Copenhaver1, I-Ching Lee, Patrick Baldwin.   

Abstract

Existing evidence-based HIV risk reduction interventions have not been designed for implementation within clinical settings, such as methadone maintenance programs, where many high-risk drug users seek treatment services. We therefore systematically developed an adapted, significantly shortened, version of a comprehensive evidence-based intervention called the Community-friendly Health Recovery Program (CHRP) which has demonstrated preliminary evidence of efficacy in a feasibility/acceptability study already published. In a randomized controlled trial reported here, we tested the efficacy of the CHRP intervention among high-risk drug users newly enrolled in drug treatment at an inner-city methadone maintenance program. The CHRP intervention produced improvements in drug risk reduction knowledge as well as demonstrated sex- and drug-risk reduction skills. Support was found for the IMB model of health behavior change. Implications for future intervention research and practice are considered.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23835735      PMCID: PMC3878981          DOI: 10.1007/s10461-013-0539-4

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  18 in total

Review 1.  Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: evidence from the scientific literature.

Authors:  Nancy D Brener; John O G Billy; William R Grady
Journal:  J Adolesc Health       Date:  2003-12       Impact factor: 5.012

Review 2.  Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment.

Authors:  Michael Copenhaver; S Kelly Avants; Lara A Warburton; Arthur Margolin
Journal:  J Psychoactive Drugs       Date:  2003 Apr-Jun

3.  We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy.

Authors:  Diane E Sholomskas; Gia Syracuse-Siewert; Bruce J Rounsaville; Samuel A Ball; Kathryn F Nuro; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2005-02

Review 4.  Changing AIDS-risk behavior.

Authors:  J D Fisher; W A Fisher
Journal:  Psychol Bull       Date:  1992-05       Impact factor: 17.737

5.  Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe.

Authors:  Alexandra M Minnis; Angella Muchini; Stephen Shiboski; Magda Mwale; Charles Morrison; Tsungai Chipato; Nancy S Padian
Journal:  Contraception       Date:  2006-09-18       Impact factor: 3.375

6.  Optimizing a community-friendly HIV risk reduction intervention for injection drug users in treatment: a structural equation modeling approach.

Authors:  Michael M Copenhaver; I-Ching Lee
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

7.  Improving representation of linguistic minorities in health surveys.

Authors:  C F Turner; S M Rogers; T P Hendershot; H G Miller; J P Thornberry
Journal:  Public Health Rep       Date:  1996 May-Jun       Impact factor: 2.792

8.  Psychological and social factors associated with histories of risk for human immunodeficiency virus infection among African-American inner-city women.

Authors:  S C Kalichman; L Y Stevenson
Journal:  J Womens Health       Date:  1997-04       Impact factor: 2.681

Review 9.  Drug abuse treatment as AIDS prevention.

Authors:  D S Metzger; H Navaline; G E Woody
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative Research, Acceptability, and Fidelity of the Options Project.

Authors:  Jeffrey D Fisher; Deborah H Cornman; Chandra Y Osborn; K Rivet Amico; William A Fisher; Gerald A Friedland
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10-01       Impact factor: 3.731

View more
  16 in total

1.  Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Authors:  Roman Shrestha; Frederick L Altice; Brian Sibilio; Jude Ssenyonjo; Michael M Copenhaver
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

2.  Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.

Authors:  Tania B Huedo-Medina; Roman Shrestha; Michael Copenhaver
Journal:  AIDS Behav       Date:  2016-08

Review 3.  Novel interventions to prevent HIV and HCV among persons who inject drugs.

Authors:  Phillip O Coffin; Christopher Rowe; Glenn-Milo Santos
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

4.  Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS).

Authors:  Laramie R Smith; Maria Luisa Mittal; Karla Wagner; Michael M Copenhaver; Chinazo O Cunningham; Valerie A Earnshaw
Journal:  Addiction       Date:  2019-11-27       Impact factor: 6.526

5.  A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis.

Authors:  Roman Shrestha; Damian Weikum; Michael Copenhaver; Frederick L Altice
Journal:  Int J Ment Health Addict       Date:  2017-04-03       Impact factor: 3.836

6.  An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy.

Authors:  Michael Copenhaver; Roman Shrestha; Jeffrey A Wickersham; Damian Weikum; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2016-01-13

7.  A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.

Authors:  Roman Shrestha; Archana Krishnan; Frederick L Altice; Michael Copenhaver
Journal:  Contemp Clin Trials       Date:  2015-08-05       Impact factor: 2.226

8.  HERMITAGE--a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers.

Authors:  Jeffrey H Samet; Anita Raj; Debbie M Cheng; Elena Blokhina; Carly Bridden; Christine E Chaisson; Alexander Y Walley; Tibor P Palfai; Emily K Quinn; Edwin Zvartau; Dmitry Lioznov; Evgeny Krupitsky
Journal:  Addiction       Date:  2014-10-16       Impact factor: 6.526

9.  The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients.

Authors:  E Jennifer Edelman; Tongtan Chantarat; Sarah Caffrey; Amina Chaudhry; Patrick G O'Connor; Linda Weiss; David A Fiellin; Lynn E Fiellin
Journal:  Drug Alcohol Depend       Date:  2014-03-15       Impact factor: 4.492

10.  Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.

Authors:  Roman Shrestha; Frederick L Altice; Pramila Karki; Michael M Copenhaver
Journal:  AIDS Behav       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.